Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody. (2015)

First Author: Kawagashira Y
Attributed to:  MICA: MRC Centre for Neuromuscular Diseases funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 25467141

Publication URI:

Type: Journal Article/Review

Volume: 348

Parent Publication: Journal of the neurological sciences

Issue: 1-2

ISSN: 0022-510X